2 unknown. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 2 |
| Phase 2 | 1 | Unknown 1 |
Follow Malignancy: new trials by email Literature Review of Malignancy trials Research Report on Malignancy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK114 AK114 - Advanced or Metastatic Solid Tumors, Malignancy | Phase 1 | Unknown | Akeso | 30 | 2022-03-15 | 2022-01-20 |
| Treatment of Malignant Tumors With NK Cell Decitabine combined with NK cell infusion - Malignancy | Phase 1 / Phase 2 | Unknown | Shenzhen University General Hospital | 60 | 2021-02-05 | 2021-12-03 |
Neoplasms (2) · Neoplasm Metastasis (1)
Neoplastic Processes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Akeso (1) · Shenzhen University General Hospital (1)
Australia (1) · China (1)
Alex HL Wong, MMedSc (1) · Li Yu, Dr (1)